Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation?

Mostafa SA, Davies MJ, Srinivasan BT, Carey ME, Webb D, Khunti K.

Postgrad Med J. 2010 Nov;86(1021):656-62. doi: 10.1136/pgmj.2009.091215. Epub 2010 Oct 18. Review.

PMID:
20956395
[PubMed - indexed for MEDLINE]
2.

Glycated haemoglobin; past, present, and future are we ready for the change.

Syed IA.

J Pak Med Assoc. 2011 Apr;61(4):383-8. Review.

PMID:
21465979
[PubMed - indexed for MEDLINE]
3.

Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.

Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H, Wu P, Teng X, Dong Y, Zhou Jw, Xu H, Zheng J, Li S, Tao T, Hu Y, Jia Y.

Acta Diabetol. 2010 Sep;47(3):231-6. doi: 10.1007/s00592-009-0143-2. Epub 2009 Sep 17.

PMID:
19760291
[PubMed - indexed for MEDLINE]
4.

The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort.

Mostafa SA, Khunti K, Srinivasan BT, Webb D, Gray LJ, Davies MJ.

Diabetes Res Clin Pract. 2010 Oct;90(1):100-8. doi: 10.1016/j.diabres.2010.06.008. Epub 2010 Jul 14.

PMID:
20633944
[PubMed - indexed for MEDLINE]
5.

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

Diabetes Care. 2001 Mar;24(3):465-71.

PMID:
11289469
[PubMed - indexed for MEDLINE]
7.

The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus.

Mostafa SA, Davies MJ, Webb D, Gray LJ, Srinivasan BT, Jarvis J, Khunti K.

Diabet Med. 2010 Jul;27(7):762-9. doi: 10.1111/j.1464-5491.2010.03015.x.

PMID:
20636956
[PubMed - indexed for MEDLINE]
8.

Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population.

Kumaravel B, Bachmann MO, Murray N, Dhatariya K, Fenech M, John WG, Scarpello TJ, Sampson MJ; University of East Anglia Impaired Fasting Glucose (UEA-IFG) Study Group.

Diabetes Res Clin Pract. 2012 May;96(2):211-6. doi: 10.1016/j.diabres.2011.12.004. Epub 2012 Jan 17.

PMID:
22257419
[PubMed - indexed for MEDLINE]
9.

Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

Diabetes Care. 1998 Aug;21(8):1221-5.

PMID:
9702423
[PubMed - indexed for MEDLINE]
10.
11.

HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose.

Geberhiwot T, Haddon A, Labib M.

Ann Clin Biochem. 2005 May;42(Pt 3):193-5.

PMID:
15949153
[PubMed - indexed for MEDLINE]
12.

Diagnostic performance of using one- or two-HbA1c cut-point strategies to detect undiagnosed type 2 diabetes and impaired glucose regulation within a multi-ethnic population.

Mostafa SA, Khunti K, Kilpatrick ES, Webb D, Srinivasan BT, Gray LJ, Davies MJ.

Diab Vasc Dis Res. 2013 Jan;10(1):84-92. doi: 10.1177/1479164112451473. Epub 2012 Jul 6.

PMID:
22773521
[PubMed - indexed for MEDLINE]
Free Article
13.

Screening for type 2 diabetes: literature review and economic modelling.

Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.

PMID:
17462167
[PubMed - indexed for MEDLINE]
Free Article
14.

Does HbA1C predict isolated impaired fasting glycaemia in the oral glucose tolerance test in subjects with impaired fasting glycaemia?

Likhari T, Aulakh TS, Singh BM, Gama R.

Ann Clin Biochem. 2008 Jul;45(Pt 4):418-20. doi: 10.1258/acb.2008.008017.

PMID:
18583629
[PubMed - indexed for MEDLINE]
15.

Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.

Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, Mitrakou A, Gerich JE.

Arch Intern Med. 2004 Aug 9-23;164(15):1627-32.

PMID:
15302632
[PubMed - indexed for MEDLINE]
16.

Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J.

Transplantation. 2009 Aug 15;88(3):429-34. doi: 10.1097/TP.0b013e3181af1f53.

PMID:
19667949
[PubMed - indexed for MEDLINE]
17.

Hemoglobin A1c for the diagnosis of diabetes: practical considerations.

Herman WH, Fajans SS.

Pol Arch Med Wewn. 2010;120(1-2):37-40. Review.

PMID:
20150843
[PubMed - indexed for MEDLINE]
Free Article
18.

The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.

Larsen ML.

Dan Med Bull. 1997 Jun;44(3):303-15. Review.

PMID:
9233549
[PubMed - indexed for MEDLINE]
19.
20.

[Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].

Kang Y, Lu JM, Sun JF, Li CL, Wang XL, Zhang XQ, Lü ZH, Dou JT, Mu YM.

Zhonghua Yi Xue Za Zhi. 2009 Mar 17;89(10):669-72. Chinese.

PMID:
19595059
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk